HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exercise tolerance in patients with angina pectoris after pentaerythritol trinitrate and alprenolol studied by two different methods.

Abstract
Exercise tolerance has been studied by two different methods, heart-rate-controlled exercise and stepwise increased load, in 12 patients with angina pectoris. The response to a beta-adrenergic blocking agent, alprenolol, and an alkyl nitrate derivative, pentaerythritol trinitrate (PETRIN) was studied by the two methods after double-blind administration of the drugs. Rating scales were used to quantitate the degree of dyspnoea, angina pectoris and tiredness in the legs. After PETRIN both methods showed significant increases in exercise tolerance (19 and 21 per cent). The heart-rate-controlled test showed a significant increase (33%) after alprenolol, but the change was not significant by the other method. In the patients studied, heart-rate-controlled exercise discriminated between active drug and placebo better than the stepwise increased load test, what might have been due to more optimal matching of the loads obtained in the heart-rate-controlled test. Indications are given about how to design an exercise study in patients with angina pectoris.
AuthorsL G Ekelund, A Melcher, L Orö
JournalEuropean journal of clinical pharmacology (Eur J Clin Pharmacol) Vol. 8 Issue 5 Pg. 309-15 (Jun 13 1975) ISSN: 0031-6970 [Print] Germany
PMID786682 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Propylene Glycols
  • Alprenolol
Topics
  • Aged
  • Alprenolol (pharmacology)
  • Angina Pectoris (physiopathology)
  • Blood Pressure (drug effects)
  • Clinical Trials as Topic
  • Exercise Test (methods)
  • Female
  • Heart Rate (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Propylene Glycols (adverse effects, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: